SCHEMBL8286378

SCHEMBL8286378

NC(=O)c1cc(C(F)(F)F)c2c(=O)cc(Nc3cccc(F)c3)n(-c3cccc(F)c3)c2n1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.49
LMNA P02545 3/20 0.36
MAPT P10636 2/20 0.36
TP53 P04637 1/20 0.36
SCN9A Q15858 4/20 0.36
MDM2 Q00987 1/20 0.35
STK10 O94804 1/20 0.34
SLK Q9H2G2 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
CD38 P28907 1/20 0.34
CCNA2 P20248 1/20 0.33
CDK2 P24941 1/20 0.33
MAOB P27338 1/20 0.33
EPHB4 P54760 2/20 0.33
RIPK1 Q13546 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285187 0.88 PDE11A (0.62) PDE11ALMNAMAPTSCN9AEPHB4
SCHEMBL8286374 0.86 PDE11A (0.45) PDE11AMAPTMDM2
SCHEMBL8287120 0.85 PDE11A (0.49) PDE11ASCN9AMDM2
SCHEMBL8287868 0.80 PDE11A (0.47) PDE11ALMNAMAPTTP53MDM2
SCHEMBL8285196 0.79 PDE11A (0.64) PDE11ALMNAMAPT
SCHEMBL8286385 0.79 PDE11A (0.79) PDE11ATP53
SCHEMBL8361753 0.78 PDE11A (0.46) PDE11ALMNAMAPTTP53MDM2
SCHEMBL8286392 0.78 PDE11A (0.62) PDE11ALMNAMAPTTP53RIPK1
SCHEMBL8286089 0.77 PDE11A (0.45) PDE11ALMNAMAPTTP53MDM2
SCHEMBL8286388 0.77 PDE11A (0.58) PDE11ASCN9AMDM2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed